Neural engineering

Labroots Hosts 12th Annual Neuroscience Online Event Scheduled on March 6, 2024

Retrieved on: 
Thursday, February 29, 2024
SVKM's NMIMS, Pennsylvania State University, Artificial intelligence, DSM-IV codes, University, Kellogg School, Behavior, Diagnosis, Health, Labroots, Associate, Gubra, Panel discussion, Bangladesh Technical Education Board, Networking hardware, Blood test, Translation, Ethics, NIH, Computer, Data collection, Aarhus University, Associate professor, Initiative, BRAIN, Dementia, Brain, Parkinson's disease, Natural language processing, University of Pennsylvania, Language, Drug discovery, BRAIN Initiative, Neurodegenerative disease, Thought, Social behavior, Heart, Translational neuroscience, Lewy body, Research, Multiple, Neural engineering, Collection, MD, Discovery, Depression, Medical imaging

YORBA LINDA, Calif., Feb. 29, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, today announced its free 12th annual event in the Neuroscience Virtual Event Series to be held on March 6, 2024. Marking a decade of sharing ground breaking research and scientific discovery via Labroots' immersive platform, this dynamic event continues its tradition of showcasing some of the brightest minds at the forefront of neuroscience impacting health and disease today.

Key Points: 
  • I am excited to discuss this at Labroots' 12th annual event in the Neuroscience Virtual Event Series."
  • Hosted by Labroots and produced on Chati, participants in the event can connect seamlessly across desktop and mobile devices while engaged in a one-stop educational experience.
  • Remember to use the hashtag #LRneuro to follow the conversation and connect with other members of the global Neuroscience community!
  • Follow @Neuroscience_LR on Twitter and @Neuroscience.LR on Facebook to stay up to date with the latest Trending News in Neuroscience.

X-trodes Receives FDA 510(k) Clearance for Wearable "Skin" Solution that Brings Medical-Grade Electrophysiological Monitoring to the Home

Retrieved on: 
Tuesday, February 20, 2024
Neural engineering, Skin, Doctor of Philosophy, Tel Aviv University, Research, FDA, Cardiology, Food, Sleep, Scientific Reports, EOG, Health, EKG, Gel, EEG, Journal, EMG, Neurology, Environment, Medical imaging

HERZLIYA, Israel, Feb. 20, 2024 /PRNewswire/ -- X-trodes, a bio-convergence company bringing wireless monitoring solutions to the home environment, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for X-trodes' Smart Skin solution (marketed as X-trodes System M), a new wireless wearable technology for advanced electrophysiological monitoring.  

Key Points: 
  • The discreet patches are easy to apply and comfortable to wear, conforming to the body without requiring gels, wires or uncomfortable solutions.
  • The FDA clearance follows successful completion of an extensive scientific assessment that evaluated the accuracy and consistency of X-trodes' system.
  • "Gaining FDA clearance affirms the value of this technology and its potential to improve health and wellness through access to real-time electrophysiological data.
  • Electrophysiological monitoring has traditionally been restricted to clinics, requiring cumbersome hardware and controlled environments to acquire highly sensitive physiological signals.

X-trodes Receives FDA 510(k) Clearance for Wearable "Skin" Solution that Brings Medical-Grade Electrophysiological Monitoring to the Home

Retrieved on: 
Tuesday, February 20, 2024
Neural engineering, Skin, Doctor of Philosophy, Tel Aviv University, Research, FDA, Cardiology, Food, Sleep, Scientific Reports, EOG, Health, EKG, Gel, EEG, Journal, EMG, Neurology, Environment, Medical imaging

HERZLIYA, Israel, Feb. 20, 2024 /PRNewswire/ -- X-trodes, a bio-convergence company bringing wireless monitoring solutions to the home environment, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for X-trodes' Smart Skin solution (marketed as X-trodes System M), a new wireless wearable technology for advanced electrophysiological monitoring.  

Key Points: 
  • The discreet patches are easy to apply and comfortable to wear, conforming to the body without requiring gels, wires or uncomfortable solutions.
  • The FDA clearance follows successful completion of an extensive scientific assessment that evaluated the accuracy and consistency of X-trodes' system.
  • "Gaining FDA clearance affirms the value of this technology and its potential to improve health and wellness through access to real-time electrophysiological data.
  • Electrophysiological monitoring has traditionally been restricted to clinics, requiring cumbersome hardware and controlled environments to acquire highly sensitive physiological signals.

alwaysAI Announces Strategic Partnership With Dr. Gabriel A. Silva, Professor of Neuroscience and Bioengineering at the University of California San Diego

Retrieved on: 
Monday, November 27, 2023
Associate, Entrepreneurship, Partnership, Brain, Research, Tau Beta Pi, SAN, Kavli Foundation (United States), Education, Faculty, UCSD, Neural engineering, Machine learning, Mind, Teaching, Biological engineering, Medical device

SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- alwaysAI, a computer vision solutions leader, announces their partnership with Dr. Gabriel Silva, Professor of Neurosciences and Bioengineering at UCSD.

Key Points: 
  • SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- alwaysAI, a computer vision solutions leader, announces their partnership with Dr. Gabriel Silva, Professor of Neurosciences and Bioengineering at UCSD.
  • As a world-leading expert in neuroscience and machine learning, Dr. Silva will collaborate with alwaysAI to further advance their computer vision technology and solutions.
  • His cutting-edge research on how the brain processes vision and recognizes objects is helping push the boundaries of computer vision and machine learning.
  • “We are thrilled to work with Dr. Silva to further strengthen the alwaysAI platform,” said Marty Beard, Co-Founder and CEO of alwaysAI.

Feinstein Institutes researchers use novel imaging technology to study how the brain and body communicate

Retrieved on: 
Tuesday, March 21, 2023
Oncology, Mental Health, Health, Hospitals, Research, Science, Inflammation, Infection, Neuron, Medicine, Diabetes, Inflammatory Bowel Diseases, Vagus nerve, Arthritis, Respiration, Neural engineering, Feinstein Institutes for Medical Research, Cancer, Skull, Brain, Multimedia, Attention, Biomedical engineering, Doctor of Philosophy, Interface (computing), Sensation, PNS, Bangladesh Technical Education Board, Paralysis, Crohn's disease, Neuroscience, Journal, Nervous system, Mouse, Heart rate, Pulmonary hypertension, Credit, Molecular medicine, NIH, Medical research, Rheumatoid arthritis, Disease, Peripheral nervous system, Medical imaging, Medical device, MD

By using calcium imaging technology to monitor neural activity from a cluster of neurons near the base of the skull, scientists hope to discover new clues about how the body communicates with the brain.

Key Points: 
  • By using calcium imaging technology to monitor neural activity from a cluster of neurons near the base of the skull, scientists hope to discover new clues about how the body communicates with the brain.
  • The researchers used imaging of the intact jugular-nodose ganglion – which contains the sensory neurons of the vagus nerve – to directly record neural activity in mice with genetically-encoded calcium indicators.
  • In this new study, Feinstein Institutes’ bioelectronic medicine researchers look at how sensory neurons encode and transmit these important physiological signals in the form of neural activity.
  • At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury.

Pixium Vision announces its cash position at 31 December 2022 and provides an update on its activities

Retrieved on: 
Tuesday, February 14, 2023
CE, Journal, Area studies, Investment, EGM, Judgement, See, AMD, Patient, Clinical trial, Stanford University, Argus retinal prosthesis, Health, Neural engineering, ESGO, Pharmaceutical industry, Cryptocurrency

Until 31 December 2022, investments in fixed and intangible assets remained low leading to a net cash outflow from investment activities of €0.1 million.

Key Points: 
  • Until 31 December 2022, investments in fixed and intangible assets remained low leading to a net cash outflow from investment activities of €0.1 million.
  • In total, at 31 December 2022, Pixium Vision’s cash position amounted to €7.7 million, compared to €14.5 million on 1 January 2022.
  • On 15 December 2022, Pixium Vision announced the completion of implantations in the European pivotal trial PRIMAvera.
  • On 28 December 2022, Pixium Vision announced welcoming the judgment by Paris Commercial Court against Second Sight Medical Products.

Apple unveils M2 Pro and M2 Max: next-generation chips for next-level workflows

Retrieved on: 
Tuesday, January 17, 2023
Software, Networks, Internet, Hardware, Data Management, Consumer Electronics, Technology, Semiconductor, Apple TV, Spotlight, IOS, IPad, Handover, IPadOS, Apple Pay, MacOS, Apple Inc., NVIDIA, FaceTime, Intel Core, CPU, ICloud, Macintosh, Quadro, Intel, Xcode, Silicon, TvOS, Adobe Photoshop, Multimedia, Life, Memory, MacBook Pro, Architecture, RAM, Running, Apple Music, SSD, Neural engineering, Indian Institute of Hardware Technology, L2, HEVC, Mac App Store, App store, 30 for 30, Computer, GPU, TB, Name, HBM2, Apple Watch, GDDR6, Apple ProRes, Carbon, MacBook, Socs, IPhone, Video game console, Computer data storage, Mobile phone, WatchOS, Apple, Mac

M2 Pro brings pro performance to Mac mini® for the first time, while M2 Pro and M2 Max take the game-changing performance and capabilities of the 14-inch and 16-inch MacBook Pro® even further.

Key Points: 
  • M2 Pro brings pro performance to Mac mini® for the first time, while M2 Pro and M2 Max take the game-changing performance and capabilities of the 14-inch and 16-inch MacBook Pro® even further.
  • View the full release here: https://www.businesswire.com/news/home/20230117005535/en/
    M2 Pro and M2 Max are next-generation chips that take the breakthrough power-efficient performance of Apple silicon to new heights.
  • (Graphic: Business Wire)
    “Only Apple is building SoCs like M2 Pro and M2 Max.
  • M2 Pro and M2 Max help the new MacBook Pro and Mac mini meet Apple’s high standards for energy efficiency.

Apple unveils MacBook Pro featuring M2 Pro and M2 Max, with more game-changing performance and the longest battery life ever in a Mac

Retrieved on: 
Tuesday, January 17, 2023
Online Retail, Consumer Electronics, Retail, Apps, Applications, Technology, Software, Hardware, Online, Apple TV, IOS, IPad, Handover, IPadOS, Apple Pay, MacOS, Apple Inc., NVIDIA, FaceTime, Intel Core, CPU, ICloud, Macintosh, Apple Store, Recycling, Quadro, XDR, Overalls, Intel, Xcode, Silicon, Environment, MacBook Pro, TvOS, Adobe Photoshop, Multimedia, Life, Metal, Memory, Aluminium, 6E, Education, Apple Specialist, Magnet, RAM, Machine learning, 3D, Apple Music, SSD, Neural engineering, HDMI, Mac App Store, Center Stage, Mac, App store, 30 for 30, Computer, GPU, TB, Name, HBM2, DaVinci Resolve, Apple Watch, MagSafe, GDDR6, Apple ProRes, PC, Carbon, SDXC, MacBook, Science, Cinema 4D, Gold, IPhone, Cassette tape, Video game console, Computer data storage, Video game, Mobile phone, Freeform, WatchOS, Motion, Apple

Apple® today announced the new 14- and 16-inch MacBook Pro® featuring M2 Pro and M2 Max, Apple’s next-generation pro silicon that brings even more power-efficient performance and battery life to pro users.

Key Points: 
  • Apple® today announced the new 14- and 16-inch MacBook Pro® featuring M2 Pro and M2 Max, Apple’s next-generation pro silicon that brings even more power-efficient performance and battery life to pro users.
  • View the full release here: https://www.businesswire.com/news/home/20230117005533/en/
    Today Apple introduced the new MacBook Pro with M2 Pro and M2 Max.
  • Available in 16- and 14-inch models, MacBook Pro delivers more performance, advanced connectivity, and the longest battery life ever in a Mac.
  • MacBook Pro with M2 Pro features a 10- or 12-core CPU with up to eight high-performance and four high-efficiency cores for up to 20 percent greater performance over M1 Pro.

X-trodes Launches First Wearable Solution for Remote Facial Electromyography (fEMG) Measurement

Retrieved on: 
Tuesday, December 13, 2022
Neural engineering, Facial, Rehabilitation, EMG, Electrode, EOG, Intellectual property, IP, Tel Aviv University, Research, Face, Journal, EEG, Brain, Doctor of Philosophy, Health, Behavior, Cognition, Medical device

HERZLIYA, Israel, Dec. 13, 2022 /PRNewswire/ -- X-trodes, a company bringing wireless monitoring solutions to the home environment, today announced it has launched a first-of-its-kind wearable and wireless facial electromyography solution for the medical, research and consumer communities.

Key Points: 
  • HERZLIYA, Israel, Dec. 13, 2022 /PRNewswire/ -- X-trodes , a company bringing wireless monitoring solutions to the home environment, today announced it has launched a first-of-its-kind wearable and wireless facial electromyography solution for the medical, research and consumer communities.
  • Facial electromyography (facial EMG or fEMG) utilizes electrodes to assess even the most subtle facial expressions and decipher emotional reactions, providing insights into a person's psychological and neurological status in order to better assess affective responses and support medical diagnosis.
  • Facial EMG technology is currently applied in a wide range of fields, including cognition monitoring, rehabilitation, neurological diagnostics, and emotion detection.
  • The X-trodes solution comprises wireless dry-printed electro patches that conform to the musculature of the face.

Pixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural Engineering

Retrieved on: 
Tuesday, October 11, 2022
Diamond, Inner nuclear layer, EN, AMF, CET, Retinal degeneration, Geographic atrophy, Neural engineering, PRIMA, Total, Vance DeGeneres, Moorfields Eye Hospital, Primavera, Retina, Research, Mnemos EP, Optical coherence tomography, Risk, Institute, Nervous system, University, Company, INL, Vision Institute, Rehabilitation, Safety, Journal, IMO, UPMC, Stanford University, AMD, Medical device, Patient

Previously, the data from the French feasibility study already demonstrated that the Prima System is well tolerated.

Key Points: 
  • Previously, the data from the French feasibility study already demonstrated that the Prima System is well tolerated.
  • The data in this paper now further demonstrate the stability and minimal impact of the implant once in position.
  • Pixium Vision is creating a world of bionic vision for those who have lost their sight, enabling them to regain visual perception and greater autonomy.
  • Prima System sub-retinal miniature photovoltaic wireless implant is in clinical testing for patients who have lost their sight due to outer retinal degeneration, initially for atrophic dry age-related macular degeneration (dry AMD).